Used in research and development for targeting interleukin-6 (IL-6) signaling pathways, this antibody has been explored in inflammatory and autoimmune conditions where IL-6 plays a key role. It has shown potential in modulating immune responses in diseases such as rheumatoid arthritis and cytokine release syndrome. Additionally, it has been investigated in oncology for its ability to interfere with IL-6-mediated tumor growth and survival signals. Its application remains primarily in preclinical and early clinical studies to understand disease mechanisms and therapeutic targeting.